VENCLEXTA Trademark

Trademark Overview


On Wednesday, March 11, 2015, a trademark application was filed for VENCLEXTA with the United States Patent and Trademark Office. The USPTO has given the VENCLEXTA trademark a serial number of 86560752. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, April 14, 2023. This trademark is owned by AbbVie Inc.. The VENCLEXTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
venclexta

General Information


Serial Number86560752
Word MarkVENCLEXTA
Filing DateWednesday, March 11, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, April 14, 2023
Registration Number5078740
Registration DateTuesday, November 8, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 23, 2015
Primary Code005
First Use Anywhere DateSaturday, April 30, 2016
First Use In Commerce DateSaturday, April 30, 2016

Trademark Owner History


Party NameAbbVie Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events


Event DateEvent Description
Saturday, March 14, 2015NEW APPLICATION ENTERED
Monday, March 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2015ASSIGNED TO EXAMINER
Tuesday, June 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 2, 2015ASSIGNED TO LIE
Saturday, July 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 11, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 11, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 30, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2016SOU EXTENSION 1 FILED
Wednesday, March 30, 2016SOU EXTENSION 1 GRANTED
Friday, April 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 4, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 4, 2016USE AMENDMENT FILED
Tuesday, October 4, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 4, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 5, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 8, 2016REGISTERED-PRINCIPAL REGISTER
Monday, November 8, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 5, 2022TEAS SECTION 8 & 15 RECEIVED
Friday, April 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 14, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 8, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED